Accelerating Drug Discovery and Personalized Treatment Using AI - Session 3

Explore how artificial intelligence is revolutionizing drug discovery and personalized medicine through the development of digital cellular twins in this 47-minute Stanford University lecture. Discover the cutting-edge research aimed at creating multimodal foundation models for cells that can simulate drug responses while accounting for individual factors like sex, age, and comorbidities before actual treatment exposure. Learn about the integration of massive biomedical datasets with advanced AI techniques to understand cellular function and state across human tissues and individuals. Examine the development of intuitive chat model interfaces designed to enhance biologists' ability to utilize and comprehend these complex cellular models. Delve into practical applications through case studies focusing on cells affected by the menstrual cycle, addressing critical questions in women's health with particular emphasis on cardiovascular disease management. The session includes a comprehensive 34-minute lecture followed by a 13-minute Q&A segment, providing insights into how end-to-end frameworks for cell modeling represent a historic opportunity to advance our understanding and treatment of human disease.